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Abstract
Background: Dengue infection can result in severe clinical manifestations requiring intensive care. Effective triage is
critical for early clinical management to reduce morbidity and mortality. However, there is limited knowledge on
early risk factors of intensive care unit (ICU) requirement. This study aims to identify early clinical and laboratory risk
factors of ICU requirement at first presentation in hospital and 24 hours prior to ICU requirement.
Method: A retrospective 1:4 matched case–control study was performed with 27 dengue patients who required
ICU, and 108 dengue patients who did not require ICU from year 2004–2008, matched by year of dengue
presentation. Univariate and multivariate conditional logistic regression were performed. Optimal predictive models
were generated with statistically significant risk factors identified using stepwise forward and backward elimination
method.
Results: ICU dengue patients were significantly older (P=0.003) and had diabetes (P=0.031), compared with
non-ICU dengue patients. There were seven deaths among ICU patients at median seven days post fever. At first
presentation, the WHO 2009 classification of dengue severity was significantly associated (P<0.001) with ICU, but
not the WHO 1997 classification. Early clinical risk factors at presentation associated with ICU requirement were
hematocrit change ≥20% concurrent with platelet <50 K [95% confidence-interval (CI)=2.46-30.53], hypoproteinemia
(95% CI=1.09-19.74), hypotension (95% CI=1.83-31.79) and severe organ involvement (95% CI=3.30-331). Early laboratory
risk factors at presentation were neutrophil proportion (95% CI=1.04-1.17), serum urea (95% CI=1.02-1.56) and alanine
aminotransferase level (95% CI=1.001-1.06). This predictive model has sensitivity and specificity up to 88%. Early
laboratory risk factors at 24 hours prior to ICU were lymphocyte (95% CI=1.03-1.38) and monocyte proportions
(95% CI=1.02-1.78), pulse rate (95% CI=1.002-1.14) and blood pressure (95% CI=0.92-0.996). This predictive model has
sensitivity and specificity up to 88.9% and 78%, respectively.
Conclusions: This is the first matched case–control study, to our best knowledge, that identified early clinical and
laboratory risk factors of ICU requirement during hospitalization. These factors suggested differential pathophysiological
background of dengue patients as early as first presentation prior to ICU requirement, which may reflect the
pathogenesis of dengue severity. These risk models may facilitate clinicians in triage of patients, after validating in larger
independent studies.
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Background
Dengue is identified as the most rapidly spreading
mosquito-borne viral disease in the world by the World
Health Organization (WHO) in 2012 [1]. Approximately
70% of the population at risk is residing in the WHO
Southeast Asia and Western Pacific regions, which make
up about 75% of the current global dengue disease bur-
den. This has led to the formation of the Asia Pacific
Dengue Strategic Plan (2008–2015) and the recent Glo-
bal Strategy for Prevention and Control (2012–2020) to
reduce the dengue burden [1].
Dengue results in a wide spectrum of non-specific
clinical manifestations with unpredictable clinical course
and outcome. Patients can be clinically classified as ‘den-
gue fever’ (DF), ‘dengue hemorraghic fever’ (DHF) or ‘den-
gue shock syndrome’ (DSS) according to the 1997 WHO
dengue classification system and it can be largely asymp-
tomatic [2]. Recently, patients can be clinically classified
as ‘probable dengue’, ‘dengue with warning signs’ or ‘severe
dengue’ according to the 2009 WHO classification system
[3]. Although a large proportion of patients recover after a
mild self-limiting disease, a small proportion may progress
to develop severe dengue clinical manifestations, which
require interventions in intensive care unit (ICU). The
progression to severe clinical manifestations is usually un-
predictable [3]. Without prompt and appropriate therapy,
case fatality rate may exceed 20% [3].
There are currently no systematic studies, but only
case series reported [4-6] focusing on epidemiological,
clinical and laboratory risk factors at first presentation in
hospital that are predictive of clinical severity, as defined
by the requirement for ICU, instead of the WHO classi-
fication criteria. Generally, the proportion of hospitalized
dengue patients requiring ICU is low (0.1%-9%) among
the high number of hospitalized cases reported [4-7], in-
cluding in Singapore [8,9]. This is likely due to the fact
that there is less severe manifestations in adult dengue
patients as compared to pediatric dengue patients, whom
are at higher risk of ICU [10]. Furthermore, the timely
diagnosis and supportive dengue care management in a
more established healthcare system, such as in Singapore
may have also resulted in only a small proportion of den-
gue cases who require ICU admission. Therefore, case
series studies and classification may not be generalizable
to all populations at risk as well as in different clinical set-
ting and healthcare system. Moreover, with the recom-
mendation of close monitoring of patients with warning
signs in hospital [3], there is a greater need to identify
these high risk dengue patients 24 hours prior to ICU re-
quirement during hospitalization, which is currently lack-
ing. Henceforth, this study aims to identify and evaluate
the early clinical and laboratory risk factors of ICU re-
quirement at first presentation in hospital as well as
24 hours prior to ICU requirement.
Methods
A retrospective matched case–control study was con-
ducted using anonymized data collected from all adult
dengue patients admitted into intensive care unit (ICU)
from 1 January 2004 to 31 December 2008 to the Depart-
ment of Infectious Diseases at Tan Tock Seng Hospital
(TTSH). This is the largest hospital in Singapore for the
treatment of dengue patients where dengue patients were
managed using a standardized dengue care path. Hos-
pitalization criteria were defined in previous published
study [8]. In Singapore, dengue infections were predomin-
antly due to dengue serotype 1 (detected in 75% to 100%
of dengue samples collected each month) during the epi-
demics in the year 2004 to 2006, and dengue serotype 2
(detected in up to 91% of dengue samples) during the epi-
demic in the year 2007 and 2008 [11]. Each case who were
admitted into ICU was randomly matched to four patients
who did not require intensive care by the year of den-
gue presentation as controls. Dengue-confirmed pa-
tients with positive dengue polymerase chain reaction
(PCR) assay, and probable dengue patients with positive
dengue immunoglobulin-M (IgM) or immunoglobulin-G
(IgG) (Dengue Duo IgM & IgG Rapid Strip, Panbio Diag-
nostic, Queensland, Australia) and fulfilling either the
WHO 1997 or 2009 probable dengue criteria, were in-
cluded in this study.
According to the WHO 1997 criteria [2], dengue fever
(DF) was defined as fever with any two of the following
manifestations: headache, retro-orbital pain, myalgia,
arthralgia, rash, hemorrhagic manifestations, or leuco-
penia. Dengue hemorrhagic fever (DHF) was diagnosed
when all four criteria of fever, hemorrhagic manifesta-
tions, thrombocytopenia (<100 × 109/L) and evidence of
plasma leakage (hematocrit change ≥20%, hypoproteine-
mia or clinical fluid accumulation) were present. Dengue
shock syndrome was diagnosed with the presence of rapid
and weak pulse with narrow pulse pressure <20 mmHg, or
hypotension in a patient with DHF. Probable dengue by
WHO 2009 criteria [3] was defined as fever and two of
the following: nausea or vomiting, rash, aches and pain,
leucopenia, and any warning sign. Warning signs were ab-
dominal pain or tenderness, persistent vomiting, clinical
fluid accumulation, mucosal bleed, lethargy or restless-
ness, hepatomegaly, and hematocrit change ≥20% concur-
rent with platelet <50 K on the same day. The WHO
warning sign of rapid change in hematocrit with rapid
drop in platelet count was qualitative. Hence, we had ex-
plored previously [9,12] using a different quantitative def-
inition of hematocrit change of ≥20% with concurrent
platelet nadir < 50 K, which is more practical to implement
in clinical setting, and had been associated with death out-
come [12]. Severe dengue cases fulfil at least one of three
criteria: (1) severe plasma leakage: associated with shock
(tachycardia >100 or narrow pulse pressure <20 or blood
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pressure <90 mmHg), (2) severe bleeding: gastrointestinal
tract bleeding such as hematemesis or melena or bleeding
per rectum, pack cell transfusion or blood transfusion re-
quirement or menorrhagia, (3) severe organ impairment:
defined as aspartate or alanine transaminase ≥1000 units/l,
encephalopathy, myocarditis and acute renal impairment
(creatinine × 2 upper limit of normal for age and sex;
based on modification of diet in renal disease equation for
glomerular filtration rate = 75 ml/min or baseline esti-
mated from minimum creatinine recorded).
The data at first presentation in hospital and 24 hours
prior to ICU requirement were obtained from medical
records: demographic, epidemiological, co-morbidity, clin-
ical, laboratory, treatment and outcome data. The severity
of the patients as evaluated by the WHO 1997 and 2009
classifications was determined at first presentation and
during hospitalisation. The duration of progression to
‘DHF’ or ‘severe dengue’ was determined only for patients
who were either classified as ‘DF’ or ‘probable dengue
with/without warning signs’ at first presentation. The
number of days post presentation (DPP) was used to de-
fine the period since the first presentation in hospital. The
number of days post fever (DPF) was used to define the
period since the day of fever onset.
Statistical methods
Univariate and multivariate conditional logistic regres-
sion were performed to assess the association between
the variables and dengue severity as defined by ICU re-
quirement. Conditional logistic regression was used to
account for the matching factor selected in the analyses
[13]. Matching was performed based on the year of pres-
entation to control for potential confounding by the pre-
dominant serotype in each year. Confounding effect was
further minimized by performing multivariate conditional
logistic regression adjusting for significant demographic &
co-morbidity factors associated with ICU requirement
only. This parsimonious approach would minimize over-
loading the multivariable model to achieve higher statis-
tical power to detect true association as the sample size
available is small [14,15]. Continuous variables were illus-
trated in median with the interquartile range (IQR) for
reference. The laboratory variables were analyzed in the
continuous format to maximize all the data available, and
to minimize reporting bias, especially when the variables
were categorized into the expected normal or hypothetical
range. For analysis of early risk factors 24 hour prior to
ICU requirement, four ICU patients were excluded as they
were admitted into ICU less than 24 hour post presen-
tation to hospital. The most optimal predictive model
was derived using the stepwise forward and backward
elimination method, with the top 10 most significantly
associated variables based on the P-value of the univar-
iate conditional regression analyses. Only variables with
P-value <0.05 would remain in the optimal model during
the model development. Hosmer–Lemeshow Goodness of
fit test was used to check if the model fit the observed
dataset with P >0.05. Likelihood ratio test was used to as-
sess if a model is more efficient than the other similar
model with more significant variables. Fisher’s exact test
and Wilcoxon rank-sum test were used for categorical and
continuous variables, respectively, for the subgroup ana-
lysis of death cases in ICU group. All statistical analyses
were performed using Stata 10.0 (Stata Corp., College
Station, TX, 2005). All tests were conducted at the 5%
level of significance, with conditional odds ratio (COR)
and/or adjusted COR (ACOR), P-value and corresponding
95% CI reported where applicable.
Ethics statement
This study was approved by Domain Specific Review
Board, National Healthcare Group, Singapore (DSRB-E/
08/567) with waiver of informed consent as data were
analyzed anonymously.
Results
A total of 8,123 dengue-infected patients were admitted
into Tan Tock Seng Hospital during the dengue epi-
demics between January 2004 and December 2008, with
national incidence rate (per 100,000 population) of about
210 in 2004, 320 in 2005, 70 in 2006, 190 in 2007, and
160 in 2008 [16]. Among these admissions, there were a
total of 27 dengue-infected cases (0.3%) that required in-
tensive care interventions in the intensive care unit
(ICU). A total of 108 dengue-infected matched controls
that did not require intensive care interventions were
involved. The median age of the cases was 44 years
[Interquartile range (IQR): 36–53 years], with 30% fe-
male and 78% Chinese. The median age of the controls
was 34 years (IQR: 25–44 years), with 36% female and
71% Chinese (Table 1). Among the cases, there were
48% positive for dengue polymerase chain reaction assay
(PCR) and 52% were serology positive. Among the con-
trols, there were 29% positive for dengue PCR, and 71%
were serology positive. The median days post fever
(DPF) at presentation was 3 (IQR: 3–5 days) and 5 days
(IQR: 4–5 days) for cases and controls, respectively. Pa-
tients requiring ICU were sicker, requiring earlier admis-
sion to hospital. However, there was no statistically
significant association observed in gender, ethnic groups,
IgG status and median DPF at first presentation with
ICU requirements.
Out of these 27 ICU cases, there were about 93% (n = 25)
who had severe plasma leakage, with 81% (n = 22) having
shock, 37% (n = 10) had severe bleeding, and 56% (n = 16)
had severe organ impairment involving renal, liver and
central nervous system during hospitalization. Among the
seven death cases, 100% had severe plasma leakage, 71%
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had severe bleeding, and 100% had severe organ in-
volvement. More descriptions can be found in Additional
file 1: Table S1 and in a previously published dengue death
study [12]. All ICU patients had intravenous (IV) fluid of
about 15 liters on average during hospitalization, and
about 40% of the ICU patients had also IV fluid before
progression to DHF/DSS. On the contrary, 86% of non-
ICU patients had IV fluid of about 4.6 liters on average
during hospitalization, and only about 8.6% had IV fluid
before progression to DHF/DSS. About 63% of the ICU
patients had received platelets infusions, while only 9.7%
of the non-ICU patients had received platelets infusions.
About 22% of the ICU patients had blood transfusion and
only about 1% of the non-ICU patients had blood transfu-
sion. About 30% of the ICU patients had required mech-
anical ventilation, and none required for the non-ICU
patients.
Demographic and co-morbidity risk factors of ICU
Age groups 50–59 years old [conditional odds ratio
(COR) = 8.51; 95% confidence interval (CI) = 1.38-52.6]
and equal to or greater than 60 years old (COR = 21.98;
95% CI = 1.97-245) had significantly higher risk of ICU
requirement compared with age group 14 to 30 years
old. However, after adjusting for diabetes mellitus, only
age group 50–59 years old was observed to be a statisti-
cally significant risk factor (adjusted COR (ACOR) = 6.9;
95% CI = 1.25-38.23) of ICU requirement (Table 1).
Among the co-morbidities analyzed, patients with dia-
betes mellitus was found to have significantly higher risk
(COR = 11.57; 95% CI = 1.25-1077) of ICU requirement
compared with patients with no diabetes. After adjusting
for age, the risk remained high with ACOR of 5.53 (95%
CI = 0.56-54.15), but it was statistically not significant,
probably due to the lack of statistical power with a small







%/(IQR) COR P-value 95% CI ACOR* P-value 95% CI
Median age 34 (25–44) 44 (36–53) 1.07 0.003 1.02–1.11 1.05 0.014 1.01–1.10
Age groups
14-30 36 33 4 15 1
30-39 32 30 7 26 3.64 0.138 0.66–20.0 2.48 0.244 0.54–11.41
40-49 24 22 7 26 5.9 0.061 0.92–37.9 4.1 0.126 0.67–25.04
50-59 13 12 6 22 8.51 0.021 1.38–52.6 6.9 0.027 1.25–38.23
≥60 3 2.8 3 11 21.98 0.012 1.97–245.2 5.49 0.165 0.50–60.54
Gender
Female 39 36 8 30 0.74 0.52 0.29–1.87 0.59 0.318 0.21–1.65
Ethnic groups
Chinese 77 71 21 78 1
Malay 5 4.6 2 7.4 1.44 0.667 0.28–7.49 2.47 0.36 0.36–17.15
Indian 15 14 2 7.4 0.45 0.344 0.09–2.37 0.39 0.315 0.06–2.47
Others 11 10 2 7.4 0.65 0.606 0.13–3.36 0.95 0.952 0.17–5.29
IgG at presentation
IgG+ 42 39 12 44 1.26 0.596 0.53–2.98 1.19 0.708 0.47–3.03
Median DPF at presentation 5 (4–5) 3 (3–5) 0.75 0.059 0.56–1.01 0.78 0.112 0.58–1.06
Diabetes mellitus
Yes 3 2.8 4 15 11.57 0.031 1.25–1077 5.53 0.142 0.56–54.15
Hypertension
Yes 10 9.3 5 19 2.22 0.184 0.69–7.17 0.42 0.296 0.08–2.14
Hyperlipidemia
Yes 7 6.5 4 15 2.57 0.168 0.67–9.83 1 0.998 0.20–4.87
Cardiac disorder
Yes 2 1.9 3 11 9.83 0.051 0.99–97.23 3.18 0.402 0.21–47.52
DPF- Days Post Fever; COR- Conditional Odds Ratio; IQR- Interquartile range.
*Adjusted Conditional Odds Ratio (ACOR) was obtained from a multivariate conditional logistic regression with test variables being adjusted by age and diabetes
mellitus.
Data in bold are risk factors significantly associated with ICU requirement.
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sample size (Table 1). In addition, patients with cardiac
disorder were observed to be at higher risk (ACOR =
3.18; 95% CI = 0.21-47.52) compared with patients with-
out. This may also be a potential risk factor that requires
further investigation, even though it was statistically not
significant in this study (Table 1).
Dengue severity classification and clinical outcomes
The WHO 1997 dengue severity classification at presen-
tation was not significantly associated with ICU require-
ment (ACOR = 1.8; 95% CI = 0.54-6.08), with sensitivity
of about 19% and specificity of 87%. However, the WHO
2009 dengue severity classification at presentation was
significantly associated with ICU requirement (ACOR =
8.79; 95% CI = 2.65-29.16) (Table 2), with sensitivity of
52% and specificity of 94%. Both the WHO dengue se-
verity classifications as final outcome were observed to
be significantly associated with ICU requirement (WHO
1997: ACOR= 2.99; 95% CI = 1.15-7.78) (WHO 2009:
ACOR = 116.4; 95% CI = 8.79-1541) (Table 2). The WHO
1997 classification system as final outcome achieved sensi-
tivity and specificity of 67% and 78%, respectively. The
WHO 2009 classification system achieved sensitivity and
specificity of 89% and 90%, respectively.
The median days of progression to DHF/DSS and se-
vere dengue for cases was 4 (IQR: 3–5 days) and 3 Days
Post Presentation (DPP) (IQR: 3–5 days), respectively.
For the controls, the median days was 3 (IQR: 2.3-
3.8 days) and 2.5 DPP (IQR: 1.8-3.3 days). The median
length of stay (LOS) in hospital was 8 (IQR: 6–13.5 days)
and 4 days (IQR: 3–5 days) for cases and controls, re-
spectively. The median Days Post Fever (DPF) and DPP
to ICU requirement was 6 (IQR: 4–7.5 days) and 3 (IQR:
2–4.5 days) days respectively. The median LOS in ICU
for the cases was 3 days (IQR: 2–4 days). Among the
cases, there were seven deaths (case fatality rate = 26%),
with median DPF of 7 days (IQR: 7–15.5 days) and
median DPP of 3 days to death (IQR: 2.5-7.5 days)
(Table 2).
Early ICU risk factors at first presentation in hospital
At first presentation, warning signs from the WHO 2009
classification were not observed to be significantly asso-
ciated with ICU requirement. In addition, other signs
and symptoms such as hemorrhagic manifestation, rash,
leucopenia, nausea/vomiting, ache and pains, thrombocyto-
penia and tardycardia were not observed to be sig-
nificantly associated with ICU requirement (Additional
file 2: Table S2). Hypoproteinemia (ACOR = 4.65; 95%
CI = 1.09-19.74), hypotension (ACOR = 7.63; 95% CI =
1.83-31.79), severe organ involvement (ACOR= 33.04; 95%
CI = 3.30-331.3) and hematocrit change ≥20% concurrent








%/(IQR) COR P-value 95% CI ACOR* P-value 95% CI
WHO 1997 (Presentation)
DHF/DSS 14 13 5 19 1.5 0.469 0.50–4.4 1.8 0.34 0.54–6.08
WHO 2009 (Presentation)
Severe dengue 7 6.5 14 52 10.3 <0.001 3.70–28.84 8.79 <0.001 2.65–29.16
WHO 1997 (Outcome)
DHF/DSS 24 22 18 67 7.65 <0.001 2.74–21.35 2.99 0.025 1.15–7.78
WHO 2009 (Outcome)
Severe dengue 11 10 24 89 73.1 <0.001 9.82–543.96 116.4 <0.001 8.79–1541
Median DPP to DHF/DSS 3 (2.3–3.8) 4 (3–5) 1.79 0.206 0.73–4.43 3.08 0.677 0.02–608
Median DPP to Severe dengue 2.5 (1.8–3.3) 3 (3–5)
Median LOS in hospital 4 (3–5) 8 (6–13.5) 1.73 <0.001 1.30–2.32 1.76 0.001 1.28–2.43
Median DPF on ICU requirement N.A 6 (4–7.5)
Median DPP on ICU requirement N.A 3 (2–4.5)
Median LOS in ICU N.A 3 (2–4)
Death 0 0 7 26
Median DPF to death N.A 7 (7–15.5)
Median DPP to Death N.A 3 (2.5–7.5)
DPF- Days Post Fever; DPP- Days Post Presentation; LOS- Length of Stay; COR- Conditional Odds Ratio; IQR- Interquartile range.
*Adjusted Conditional Odds Ratio (ACOR) was obtained from a multivariate conditional logistic regression with test variables being adjusted by age and diabetes
mellitus.
Data in bold are risk factors significantly associated with ICU requirement.
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with platelet <50 K (ACOR = 8.66; 95% CI = 2.46-30.53)
were observed to be significantly associated with ICU re-
quirement (Table 3).
Pulse rate (ACOR = 1.05; 95% CI = 1.01-1.09), neutrophil
proportion (ACOR = 1.11; 95% CI = 1.04-1.17), serum urea
(ACOR = 1.26; 95% CI = 1.02-1.56), creatinine (ACOR =
1.02; 95% CI = 1.01-1.04), aspartate (ACOR = 1.01; 95%
CI = 1.001-1.06) (AST) and alanine aminotransferases
(ALT), (ACOR = 1.01; 95% CI = 1.001-1.06) at first pres-
entation were positively correlated with ICU requirement
(Table 3). On the contrary, lymphocyte (ACOR = 0.90;
95% CI = 0.85-0.96) monocyte proportions (ACOR= 0.86;
95% CI = 0.77-0.95), platelet count (ACOR = 0.98; 95%
CI = 0.96-0.99), serum protein (ACOR= 0.88; 95% CI =
0.79-0.98) and albumin (ACOR= 0.81; 95% CI = 0.70-0.94)
at first presentation were significantly and negatively
correlated with ICU requirement (Table 3).
These early risk factors of ICU requirement at first pres-
entation in hospital were used to create a predictive model.
The most optimal model derived was a combination of
neutrophil proportion, ALT and serum urea level with an
area under the curve (AUC) of 0.92 (Hosmer–Lemeshow
Goodness of fit test P = 0.52), indicating that the model
had good discrimination of patients who are more likely
to require ICU when screened at first presentation in hos-
pital. A prognostic index (P) was created using this model.
Using the default cut-off of P = 0, the model had sensitivity
of 58.8%, specificity of 96.3%, positive predictive value
(PPV) of 76.9% and negative predictive value (NPV) of
91.8%. Using a cut-off of P = −1.4 (maximizing sensitivity
and specificity), the model had sensitivity of 88.2%, specifi-
city of 88.9%, PPV of 62.5% and NPV of 97.3%. The pre-
dicted probability of ICU requirement (pi) at presentation
was calculated as follows:
Ppresentation ¼ lnð pi1− piÞ ¼ 0:106x 1i þ 0:004x 2i þ 0:326x 3i
− 10:601
Table 3 Significantly associated clinical and laboratory variables at first presentation of dengue-infected ICU (cases)








%/(IQR) COR P-value 95% CI ACOR* P-value 95% CI
Hypoproteinemia
Yes 23 21 10 37 2.28 0.085 0.89–5.85 4.65 0.037 1.09–19.74
Hypotension
Yes 4 3.7 7 26 8.62 0.002 2.21–33.63 7.63 0.005 1.83–31.79
Severe organ involvement
Yes 1 0.9 10 37 40 <0.001 5.12–312.5 33.04 0.003 3.30–331.3
Hematocrit change
≥20% concurrent
with platelet <50 K
Yes 7 6.5 11 41 9.4 <0.001 2.95–29.83 8.66 0.001 2.46–30.53
Systolic blood pressure 105 (100–114) 110 (91.5–118.5) 0.98 0.216 0.96–1.01 0.97 0.046 0.94–0.99
Pulse rate 90 (80–96) 95.5 (88.5–102) 1.03 0.049 1.00–1.07 1.05 0.012 1.01–1.09
Proportion neutrophils 60.3 (46.2–70.4) 76.8 (70.7–81.5) 1.11 <0.001 1.05–1.18 1.11 0.001 1.04–1.17
Proportion lymphocytes 30.3 (22–39) 16.5 (9.8–19.9) 0.90 <0.001 0.85–0.95 0.90 0.001 0.85–0.96
Proportion monocytes 12.5 (8.9–17.3) 7.9 (5.1–9.9) 0.84 0.002 0.76–0.94 0.86 0.004 0.77–0.95
Platelet 68 (44–84) 42.5 (20.3–74.8) 0.98 0.01 0.96–0.99 0.98 0.017 0.96–0.99
Serum urea 3.5 (2.6–4.6) 5.1 (3.7–6.8) 1.33 0.002 1.11–1.58 1.26 0.030 1.02–1.56
Serum creatinine 77 (65–88.3) 102 (82.3–130) 1.03 0.001 1.01–1.04 1.02 0.006 1.01–1.04
Serum AST 114 (70–195) 156.5 (96.5–516) 1.01 0.017 1.00–1.04 1.01 0.019 1.00–1.04
Serum ALT 74 (38–121) 92 (55.8–293.3) 1.01 0.012 1.001–1.06 1.01 0.017 1.001–1.06
Serum protein 67 (63–72) 66 (60.5–68.5) 0.89 0.016 0.79–0.98 0.88 0.022 0.79–0.98
Serum albumin 37 (35–40) 37 (31–39) 0.8 0.004 0.69–0.93 0.81 0.006 0.70–0.94
DPF- Days Post Fever; DPP- Days Post Presentation; LOS- Length of Stay; COR- Conditional Odds Ratio; IQR- Interquartile range.
*Adjusted Conditional Odds Ratio (ACOR) was obtained from a multivariate conditional logistic regression with test variables being adjusted by age and diabetes
mellitus. Data in bold are risk factors involved in the most optimal predictive model of ICU requirement at first presentation.
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For each individual i, x1 to x3 are indicator variables
taking on respective values, where x1 represents neutro-
phil proportion (%), x2 represents ALT (IU/L) and x3
represents serum urea (mmol/L).
Early ICU risk factors at 24 hours prior to ICU requirement
Close monitoring of high risk patients in hospital for
ICU requirement may be challenging as clinical condi-
tions can evolve unpredictably. We further explored
potential risk factors that can provide stratification at
24 hours prior to ICU requirement after their first pres-
entation in hospital. Pulse rate (COR = 1.07; 95% CI =
1.002-1.14), white cell count (COR = 1.59; 95% CI = 1.04-
2.44), lymphocyte (COR = 1.19; 95% CI = 1.03-1.38) and
monocyte proportions (COR = 1.35; 95% CI = 1.02-1.78)
were observed to be significantly higher in ICU dengue
patients 24 hour before ICU requirement compared with
these at first presentation (Table 4). On the contrary,
blood pressure (COR = 0.96; 95% CI = 0.92-0.996) and
hematocrit (COR = 0.81; 95% CI = 0.66-0.99) were ob-
served to be significantly lower in ICU dengue patients
24 hour prior to ICU requirement compared with that
at the first presentation (Table 4). The most optimal
model derived was a combination of the monocyte and
lymphocyte proportion, blood pressure and pulse rate,
which had an AUC of 0.94 (Hosmer–Lemeshow Good-
ness of fit test P = 0.96), indicating that the model had
good predictive potential of a high risk dengue-infected
patient who is likely to require ICU in the next 24 hour.
In addition, this model is more efficient than the model
that is comprised of only pulse rate and blood pressure,
which are known critical factors for ICU requirement,
and has an AUC of only 0.74. A prognostic index (P)
was thus, created using the model with monocyte and
lymphocyte proportion, blood pressure and pulse rate.
Using the default cut-off of P = 0, the model had sensi-
tivity of 74.1%, specificity of 88%, PPV of 87% and NPV
of 75.9%. Using a cut-off of P = −0.4 (maximizing sensi-
tivity and specificity), the model had sensitivity of 88.9%,
specificity of 76%, PPV of 80% and NPV of 86.4%. The
predicted probability of ICU requirement in the next
24 hour (pi) was calculated as follows:
P24HpriorICU ¼ lnð pi1− piÞ ¼ 0:333x 1i − 0:105x2i þ 0:079x 3i
þ 0:188x 4i − 5:284
For each individual i, x1 to x3 are indicator variables
taking on respective values, where represents x1 mono-
cyte proportion (%), x2 blood pressure (mHg), x3 pulse
rate (bpm) and x4 lymphocyte proportion (%).
Differential clinical and laboratory features of death cases
at first presentation among the ICU cases
A subgroup analysis was performed among the ICU
cases to explore the significantly different clinical and la-
boratory features of death cases at first presentation in
hospital (Table 5; Additional file 1: Table S1). The me-
dian age for death ICU cases (n = 7) and non-death ICU
(n = 20) subgroups was 48 (IQR: 27–50.5) and 43 (IQR:
36.8-54.3) years old, respectively. There were about 30%
female in both the death and non-death subgroups (P = 1;
Additional file 1: Table S1). Based on the 2009 WHO
classification, 100% and 85% had severe dengue in the
death and non-death subgroups, respectively (P = 0.545;
Additional file 1: Table S1). The median length of stay in
ICU was 3 and 3.5 days for the death and non-death sub-
groups, respectively (P = 0.383; Additional file 1: Table S1).
The median length of stay in hospital was 4 and 9 days for
death and non-death subgroups (P = 0.029). Importantly,
the following characteristics at first presentation were ob-
served to be significantly different between the death and
non-death ICU subgroups: having any warning signs (P =
0.022), monocyte (P = 0.035) and eosinophils proportions
(P = 0.035), serum AST (P = 0.049) and ALT (P = 0.010),
and protein (P = 0.039) (Table 5).
Discussion
Dengue infection results in a wide spectrum of clinical se-
verity, from self-limiting dengue fever to severe dengue.
Timely appropriate monitoring and clinical management,
Table 4 Significantly associated laboratory variables at 24 h prior to ICU requirement compared to first presentation
of dengue-infected ICU (cases) patients
Variables Den-infected ICU at
presentation (n = 23)^
(IQR) Den-infected ICU at 24 H
prior ICU (n = 23)^
(IQR) COR P-value 95% CI
Systolic blood pressure 110 (91.5–118.5) 90 (80–101.5) 0.96 0.03 0.92–0.996
Pulse rate 95.5 (88.5–102) 101 (90.5–117.5) 1.07 0.044 1.002–1.14
White cell count 3.3 (2.4–4.2) 4.9 (3–7.4) 1.59 0.033 1.04–2.44
Proportion lymphocytes 16.5 (9.8–19.9) 23.5 (18.1–28.6) 1.19 0.020 1.03–1.38
Proportion monocytes 7.9 (5.1–9.9) 12.1 (9.1–17.9) 1.35 0.033 1.02–1.78
Serum hematocrit 44.9 (42.8–47.2) 40.2 (33.6–43.6) 0.81 0.037 0.66–0.99
COR- Conditional Odds Ratio; IQR- Interquartile range.
^- Four cases were excluded as they were admitted into ICU less than 24 hours after first presentation at hospital. Data in bold are risk factors involved in the
most optimal predictive model of ICU requirement at 24h prior to ICU requirement.
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mainly with fluid interventions of dengue patients is crit-
ical to reduce morbidity and mortality [2,3]. Some of these
patients may also require critical clinical management in
intensive care unit (ICU). Healthcare resources such as
ICU beds and close monitoring may be limited during a
large epidemic, making effective triage of patients who
may require ICU requirement more crucial. However,
there is currently a lack of systematic study looking at po-
tential early risk factors for ICU requirement. Early clinical
and laboratory risk factors during first presentation at hos-
pital or even 24 hours prior to ICU requirement via regu-
lar strict monitoring of risk factors, may assist clinicians to
triage these high-risk patients.
From this matched case–control study, dengue pa-
tients who were either between 50 to 59 years old or
with pre-existing diabetes had about five times the risk
of ICU requirement, compared with dengue patients
who are less than 30 years old or without diabetes, re-
spectively (Table 1). Age group 50 to 59 years old was
also implicated in ICU requirement in a case–control
study of dengue fatality [17] and the recent multi-center
mortality cohort study in Singapore [12]. However, the
age risk factor of dengue hemorrhagic fever (DHF) ob-
served in a dengue 2 epidemic is age group of 30–49
years old [18]. This suggests that different severity, either
defined as DHF, fatality or the requirement for ICU re-
quirement, may affect different age groups. Furthermore,
age group of 60 years old and above was not observed to
be a risk factor of ICU requirement previously [19,20],
which supported the observation in this study. On the con-
trary, it was observed that the mean age of ICU require-
ment in New Delhi case series was younger (39.6 years)
[4], with about only 10% of the ICU dengue patients aged
greater than 55 years, compared with the 22% in this
study. In addition, in southern Taiwan, dengue patients
65 years old or above were reported to have a higher fatal-
ity risk compared with patients less than 65 years of age
[20]. Interestingly, there was no significant difference in
age between severe cases requiring ICU and benign cases
in a dengue serotype 1 epidemic in New-Caledonia (South
Pacific), with mean age of 47 years in both groups [5].
These findings highlighted the potential differences in
epidemiology of ICU dengue patients in different geo-
graphical regions, which would be interesting for further
evaluation. In general, the risk of ICU requirement was
observed to increase from age 40 years old and above
(Table 1). Diabetes was not an independent risk factor of
ICU requirement in this study (even after adjusting for
DHF; data not shown), which is also similarly reported in
dengue mortality studies [12,17,21]. However, diabetes
was shown to be an independent risk factor of DHF as an
outcome [18,22], and DHF as an outcome was signifi-
cantly associated with ICU requirement in this study. This
may suggest that having diabetes may not predispose a pa-
tient to ICU requirement or death directly, but it may in-
crease the risk of DHF, potentially resulting in ICU
requirement. However, caution in interpretation remains
as the sample size of cases was small in this study. Fur-
thermore, IgG status was not significantly associated with
ICU requirement, hence, secondary infection is not likely
to confound the associations observed in this study.
Based on the WHO classification at presentation, pa-
tients who fulfilled the WHO 2009 severe dengue classi-
fication were at a higher risk of ICU requirement, eight
times more than patients classified as non-severe, but
not for the WHO 1997 DHF/DSS criteria at first presenta-
tion (Table 2). This suggests that the WHO 2009 classifi-
cation for severe dengue is more sensitive in identifying
clinically more severe patients than that of the WHO 1997
classification for DHF/DSS at first presentation, which is
Table 5 Significantly different characteristics between deaths and non-deaths at first presentation in the subgroup
analysis of ICU dengue-infected patients
Variables Den-infected ICU
non-death (n = 20)
%/(IQR) Den-infected ICU
death (n = 7)
%/(IQR) P-value*
Median LOS in hospital 9 (7–17.25) 4 (3.5–8.5) 0.0285
Median DPF to death 0 3 (2.5–7.5)
Median DPP to death 0 7 (7–15.5)
Any warning sign
Yes 9 45 7 100 0.022^
Proportion monocytes 9.1 (6.55–12.55) 5.4 (3.8–7.15) 0.0348
Proportion eosinophils 0.1 (0–0.4) 0.5 (0.4–0.9) 0.0351
Serum AST 11 (10–17) 19 (16–29) 0.0487
Serum ALT 126 (70.25–263.25) 939 (442.75–1577.75) 0.0103
Serum protein 85.5 (39.25–146.25) 491 (159–653.5) 0.0328
^- Fisher’s exact test.
*- Wilcoxon rank-sum test.
IQR- Interquartile range.
Pang et al. BMC Infectious Diseases 2014, 14:649 Page 8 of 11
http://www.biomedcentral.com/1471-2334/14/649
also reported in other studies [10,12,23]. However, both
the WHO 1997 and 2009 classification systems only
achieved sensitivity of about 19% and 52%, respectively, in
differentiating patients who required ICU requirement at
first presentation. On the other hand, both classification
systems achieved high specificity of 87% and 94%, respect-
ively. In contrast, as final outcome, the WHO 1997 classi-
fication system achieved sensitivity and specificity of about
67% and 78% respectively, and the WHO 2009 classifica-
tion system achieved sensitivity and specificity of about
89% and 90% respectively. This is comparable to the sensi-
tivity and specificity of identifying patients requiring cat-
egory III care (which includes ICU requirement) for DHF/
DSS (39.0% and 75.5%, respectively) and for severe dengue
(92.1% and 78.5%, respectively) as described by Narvaez F
et al. [10].
Most warning signs and symptoms at first presentation
in this study were not observed as risk factors of ICU re-
quirement in this study, except for hypoproteinemia,
hypotension, and hematocrit change ≥20% concurrent
with platelet <50 K (Table 3). Other studies also reported
that most warning signs were not able to identify pa-
tients progressing into DHF, severe dengue, category III
care or fatality efficiently [9,10,20]. However, gastrointes-
tinal symptoms were proposed as an important warning
sign for severe dengue and fatality [20,22], but it was not
associated with ICU requirement in this study. Hypopro-
teinemia was observed in most (>80%) of the fatal cases
in other studies [12,24], and was observed at first pres-
entation of severe patients who required ICU require-
ment [5]. Similarly, hypotension was observed in 71% of
fatal cases [17], and was observed to be significantly
more in severe cases who required ICU [5]. Interestingly,
having any warning signs at first presentation is also a
risk factor for death among ICU cases (Table 5), besides
for severe dengue [25].
The following laboratory parameters at presentation
may be potential indicators of ICU requirement at first
presentation in hospital, and were reported in ICU re-
quirement case series and/or fatality case–control studies:
pulse rate [17], neutrophil [5], lymphocytes and mono-
cytes proportions, platelet count [6,7,17,21,24], serum
urea, creatinine [5,7,17], AST, ALT [5-7,17,24], protein
[5,7] and albumin [5,7,17,24]. In our study, a prognostic
model using a combination of neutrophil proportion, ALT
and serum urea level provided a sensitivity of 88.2%, speci-
ficity of 88.9%, PPV of 62.5% and NPV of 97.3%. This is
comparable to the models for predicting severity, defined
as death using a model comprised of creatinine, free bili-
rubin, amylase and platelets with PPV 66.7% and NPV
75.5% [5], and the prediction of DHF in adult patients at
presentation with median DPF of 5 days using a model
comprised of clinical bleeding, serum urea, serum protein,
and lymphocyte proportion with sensitivity 83%, specificity
84%, PPV 18%, NPV 99% [26-28]. Serum urea level was a
common variable in these models, which suggests urea
level in serum may be an important risk factor for severity.
However, the level of serum urea is influenced by bleeding,
renal failure, and changes in hemoconcentration. Hence,
further research is still required to elucidate the impact of
urea on dengue severity, which was shown previously to
increase complement-fixation of dengue antigen [29].
Monocyte proportion, AST, ALT and serum proteins were
also observed to be significantly different between the
death and non-death among ICU cases. This suggests that
these could be important factors involved in the progres-
sion of fatality after ICU requirement, and should be con-
sidered for close monitoring during hospitalization. On
the contrary, only bandemia was highlighted as a signifi-
cant risk factor at first presentation between non-fatal and
fatal patients [21].
Pulse rate, lymphocyte and monocyte proportions,
blood pressure, white cell count, and hematocrit were
observed as early risk factors at 24 hours prior to ICU
requirement, and were reported in ICU requirement
case series and/or fatality case–control studies [4,17,21].
In the fatality study, leukocytosis and platelet count were
also shown to be significantly different between the first
presentation and pre-fatal data [21]. Interestingly,
lymphocyte and monocyte proportions of ICU dengue
patients at 24 hours prior to ICU requirement was sig-
nificantly greater compared with that at first presenta-
tion, but lower compared with non-ICU dengue patients
at first presentation. This may suggest the dynamic dif-
ferences in immune response between dengue patients
who required ICU requirement and dengue patients
who did not require ICU requirement were already evi-
dent even at first presentation, which is about three to
five days post fever. In addition, this may reflect the ob-
servation of the immune response changes rapidly over
time as a patient progresses from first presentation at
hospital to 24 hours before ICU requirement in another
study [30]. However, further research is required to valid-
ate these observation. A prognostic model using a com-
bination of monocytes and lymphocytes proportion, blood
pressure and pulse rate provided a sensitivity of 74.1%,
specificity of 88%, PPV of 87% and NPV of 75.9%. Some of
these significant variables were also part of the model used
for predicting pediatric DHF which comprised of white
cell count, monocytes proportion, platelet count, and
hematocrit with sensitivity of 97% and specificity of 48%
[31]. Furthermore, this model is clinically relevant as pulse
rate and blood pressure were known critical factors for
ICU requirement, and were selected unbiasedly based on
its significance by the regression techniques. Furthermore,
this model was observed to be more efficient as compared
to the predictive model with only pulse rate and blood
pressure as significant variables.
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There are some limitations in our study that should be
taken into consideration when interpreting the results.
First, the study had a relatively small number of patients
with ICU requirement that may result in low statistical
power to detect true association. However, the power
was maximized by using four matched controls to each
case. Furthermore, it should be noted that Tan Tock
Seng Hospital is a major infectious disease center in
Singapore, which provided care for about 40% of all re-
ported dengue patients in Singapore. Second, no dengue
serotype data were available for individual study sub-
jects. In order to account for the serotype variable, we
used the year of dengue presentation as a surrogate for
serotype (as describe in Methods) as well as a matching
factor for our selection of controls to minimize confound-
ing effect due to the different predominant serotype each
year. Third, there were no data on pharmaceutical inter-
vention prior and during hospitalization to account for po-
tential contribution to disease severity due to chronic
diseases. However, since both the ICU and non-ICU den-
gue patients did not have significant differences in pre-
existing comorbidities, the bias due to pharmaceutical
interventions on severity outcome should be minimal.
Fourth, this model is derived from adult dengue patients
presenting to hospital at a median of 5 DPF (IQR = 3–5
days). Hence, the model may be less accurate when used
for triage of patients outside this period range, or used at
the community healthcare facilities, which may have much
shorter days post fever. Further validation studies are still
required to confirm the validity and reliability of this
model. Fifth, three parameters in our probability equation
were laboratory test results, which may not be easily avail-
able in resource-poor countries. However, it is hopeful
that as the awareness of dengue prevention and clinical
management is raised with the guidance of the WHO,
there will be an increased in public-private partnerships
that can help to resolve this challenge gradually. Sixth, the
lack of APACHE II or SOFA scores may have further limit
the accuracy and performance of these model develop-
ment. Lastly, these risk factors and models would not be
as useful as expected if there is a lack of commitment of
all hospital physicians, particularly in emergency units, to
ensure close monitoring of patients during hospitalization
using the risk factors identified in this study.
Conclusion
Studies to assess early risk factors for severity as defined
by DHF/DSS and severe dengue for effective triage are
important. However, dengue severity as defined by the
requirement of ICU is also critical, but lacking. This is
the first systematic study, to our best knowledge, that
highlighted the differential pathophysiological background
of dengue patients at presentation and at 24 hours prior to
ICU requirement. Demographic and clinical risk factors
for triage at first presentation comprised of age group 50
to 59 years old, pre-existing diabetes, the WHO 2009 clas-
sification at first presentation, hypoproteinemia, hypo-
tension and hematocrit change ≥20% concurrent with
platelet <50 K were proposed. For laboratory risk factors,
two optimal models with significantly associated variables
were derived and proposed to complement the WHO clas-
sification system. An optimal model at first presentation is
comprised of neutrophil proportion, ALT and serum urea
level, and another optimal model for assessing severity
24 hours prior to ICU requirement is comprised of mono-
cytes and lymphocytes proportions, blood pressure and
pulse rate. This would be useful to identify dengue patients
who may require ICU requirement early at presentation as
well as during hospitalization for closer monitoring and
clinical management to reduce morbidity and mortality,
when validated in independent larger studies.
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